Movimento Duchenne

1 Flanigan KM. Duchenne and Becker muscular dystrophies. Neurol Clin 2014; 32: 671–688.

2 The Diagnosis and Management of Duchenne.Muscular.Distrophy. Disponível em: http://www.dmd-guide.org/disease-stages/overview. Acesso em 29/06/2020.

3 Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018;17(3):251-267.

4 Genetics Home Reference. Help Me Understand Genetics Precision Medicine. U.S. National Library of Medicine – National Institutes of Health. Department of Health & Human Services. 2016:1-10. Disponível em: <https://ghr.nlm.nih.gov/primer>. Acesso em: 18 fev. 2020.

5 Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010 Feb;9(2):177-89. https://doi.org/10.1016/S1474-4422(09)70272-8.

6 Bula de Translarna® (atalureno). Anvisa. Disponível em: <http://www.anvisa.gov.br/datavisa/fila_bula/ index.asp>. Acesso em: ago. 2020.

7 Verhaart IEC, Aartsma-Rus A. Therapeutic developments for Duchenne muscular dystrophy. Nat Rev Neurol. 2019;15(7):373-386.